Stay updated on Biomarker-Directed Therapy in mCRC Clinical Trial

Sign up to get notified when there's something new on the Biomarker-Directed Therapy in mCRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker-Directed Therapy in mCRC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T13:58:20.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page has been updated to include new drug names related to colorectal cancer treatment, specifically Atezolizumab, Vemurafenib, Bevacizumab, Trastuzumab, Pertuzumab, Cobimetinib, 5-FU/LV, and Capecitabine, while significant details about a clinical trial have been removed.
    Difference
    23%
    Check dated 2025-04-16T02:50:35.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T00:38:50.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T19:04:42.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-03-03T22:28:50.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.5%
    Check dated 2025-02-10T10:17:47.000Z thumbnail image

Stay in the know with updates to Biomarker-Directed Therapy in mCRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker-Directed Therapy in mCRC Clinical Trial page.